Report Detail
Global Novel Drug Delivery Systems Market Insights, Forecast to 2025
- RnM3370803 |
- 01 May, 2019 |
- Global |
- 144 Pages |
- QYResearch |
- Pharma & Healthcare
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.
The global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2018 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Novel Drug Delivery Systems market based on company, product type, end user and key regions.
This report studies the global market size of Novel Drug Delivery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Novel Drug Delivery Systems in these regions.
This research report categorizes the global Novel Drug Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Novel Drug Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
TOLMAR
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Bausch＆Lomb
TWi Pharmaceuticals
Novartis
Aspen
Shire
Breckenridge Pharmaceuticals
Galen
Market size by Product
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market size by End User
Hospitals & Clinic
Cancer Treatment Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Novel Drug Delivery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Novel Drug Delivery Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Novel Drug Delivery Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Novel Drug Delivery Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Novel Drug Delivery Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Novel Drug Delivery Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Novel Drug Delivery Systems Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Product
- 1.4.2 Liposomes
- 1.4.3 PEGylated Proteins & Polypeptides
- 1.4.4 Polymer Nanoparticle
- 1.4.5 Protein–drug Conjugates
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Novel Drug Delivery Systems Market Size Growth Rate by End User
- 1.5.2 Hospitals & Clinic
- 1.5.3 Cancer Treatment Centers
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Novel Drug Delivery Systems Market Size
- 2.1.1 Global Novel Drug Delivery Systems Revenue 2014-2025
- 2.1.2 Global Novel Drug Delivery Systems Sales 2014-2025
- 2.2 Novel Drug Delivery Systems Growth Rate by Regions
- 2.2.1 Global Novel Drug Delivery Systems Sales by Regions
- 2.2.2 Global Novel Drug Delivery Systems Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Novel Drug Delivery Systems Sales by Manufacturers
- 3.1.1 Novel Drug Delivery Systems Sales by Manufacturers
- 3.1.2 Novel Drug Delivery Systems Sales Market Share by Manufacturers
- 3.1.3 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
- 3.2 Novel Drug Delivery Systems Revenue by Manufacturers
- 3.2.1 Novel Drug Delivery Systems Revenue by Manufacturers (2014-2019)
- 3.2.2 Novel Drug Delivery Systems Revenue Share by Manufacturers (2014-2019)
- 3.3 Novel Drug Delivery Systems Price by Manufacturers
- 3.4 Novel Drug Delivery Systems Manufacturing Base Distribution, Product Types
- 3.4.1 Novel Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Novel Drug Delivery Systems Product Type
- 3.4.3 Date of International Manufacturers Enter into Novel Drug Delivery Systems Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Novel Drug Delivery Systems Sales by Product
- 4.2 Global Novel Drug Delivery Systems Revenue by Product
- 4.3 Novel Drug Delivery Systems Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Novel Drug Delivery Systems Breakdown Data by End User
6 North America
- 6.1 North America Novel Drug Delivery Systems by Countries
- 6.1.1 North America Novel Drug Delivery Systems Sales by Countries
- 6.1.2 North America Novel Drug Delivery Systems Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Novel Drug Delivery Systems by Product
- 6.3 North America Novel Drug Delivery Systems by End User
7 Europe
- 7.1 Europe Novel Drug Delivery Systems by Countries
- 7.1.1 Europe Novel Drug Delivery Systems Sales by Countries
- 7.1.2 Europe Novel Drug Delivery Systems Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Novel Drug Delivery Systems by Product
- 7.3 Europe Novel Drug Delivery Systems by End User
8 Asia Pacific
- 8.1 Asia Pacific Novel Drug Delivery Systems by Countries
- 8.1.1 Asia Pacific Novel Drug Delivery Systems Sales by Countries
- 8.1.2 Asia Pacific Novel Drug Delivery Systems Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Novel Drug Delivery Systems by Product
- 8.3 Asia Pacific Novel Drug Delivery Systems by End User
9 Central & South America
- 9.1 Central & South America Novel Drug Delivery Systems by Countries
- 9.1.1 Central & South America Novel Drug Delivery Systems Sales by Countries
- 9.1.2 Central & South America Novel Drug Delivery Systems Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Novel Drug Delivery Systems by Product
- 9.3 Central & South America Novel Drug Delivery Systems by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Novel Drug Delivery Systems by Countries
- 10.1.1 Middle East and Africa Novel Drug Delivery Systems Sales by Countries
- 10.1.2 Middle East and Africa Novel Drug Delivery Systems Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Novel Drug Delivery Systems by Product
- 10.3 Middle East and Africa Novel Drug Delivery Systems by End User
11 Company Profiles
- 11.1 Amgen
- 11.1.1 Amgen Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Amgen Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Amgen Novel Drug Delivery Systems Products Offered
- 11.1.5 Amgen Recent Development
- 11.2 Teva
- 11.2.1 Teva Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Teva Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Teva Novel Drug Delivery Systems Products Offered
- 11.2.5 Teva Recent Development
- 11.3 UCB (Union Chimique Belge)
- 11.3.1 UCB (Union Chimique Belge) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Products Offered
- 11.3.5 UCB (Union Chimique Belge) Recent Development
- 11.4 Roche
- 11.4.1 Roche Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Roche Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Roche Novel Drug Delivery Systems Products Offered
- 11.4.5 Roche Recent Development
- 11.5 Celgene
- 11.5.1 Celgene Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Celgene Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Celgene Novel Drug Delivery Systems Products Offered
- 11.5.5 Celgene Recent Development
- 11.6 Sanofi
- 11.6.1 Sanofi Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi Novel Drug Delivery Systems Products Offered
- 11.6.5 Sanofi Recent Development
- 11.7 Merck
- 11.7.1 Merck Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck Novel Drug Delivery Systems Products Offered
- 11.7.5 Merck Recent Development
- 11.8 Johnson & Johnson
- 11.8.1 Johnson & Johnson Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Johnson & Johnson Novel Drug Delivery Systems Products Offered
- 11.8.5 Johnson & Johnson Recent Development
- 11.9 Takeda
- 11.9.1 Takeda Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Takeda Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Takeda Novel Drug Delivery Systems Products Offered
- 11.9.5 Takeda Recent Development
- 11.10 Gilead Sciences
- 11.10.1 Gilead Sciences Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Gilead Sciences Novel Drug Delivery Systems Products Offered
- 11.10.5 Gilead Sciences Recent Development
- 11.11 Pfizer
- 11.12 Dr Reddy
- 11.13 Samyang Biopharmaceuticals
- 11.14 TOLMAR
- 11.15 Astellas
- 11.16 AMAG Pharmaceuticals
- 11.17 AstraZeneca
- 11.18 AbbVie
- 11.19 Bausch＆Lomb
- 11.20 TWi Pharmaceuticals
- 11.21 Novartis
- 11.22 Aspen
- 11.23 Shire
- 11.24 Breckenridge Pharmaceuticals
- 11.25 Galen
12 Future Forecast
- 12.1 Novel Drug Delivery Systems Market Forecast by Regions
- 12.1.1 Global Novel Drug Delivery Systems Sales Forecast by Regions 2019-2025
- 12.1.2 Global Novel Drug Delivery Systems Revenue Forecast by Regions 2019-2025
- 12.2 Novel Drug Delivery Systems Market Forecast by Product
- 12.2.1 Global Novel Drug Delivery Systems Sales Forecast by Product 2019-2025
- 12.2.2 Global Novel Drug Delivery Systems Revenue Forecast by Product 2019-2025
- 12.3 Novel Drug Delivery Systems Market Forecast by End User
- 12.4 North America Novel Drug Delivery Systems Forecast
- 12.5 Europe Novel Drug Delivery Systems Forecast
- 12.6 Asia Pacific Novel Drug Delivery Systems Forecast
- 12.7 Central & South America Novel Drug Delivery Systems Forecast
- 12.8 Middle East and Africa Novel Drug Delivery Systems Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Novel Drug Delivery Systems Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Novel Drug Delivery Systems. Industry analysis & Market Report on Novel Drug Delivery Systems is a syndicated market report, published as Global Novel Drug Delivery Systems Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Novel Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
